Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 9, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 1, 2026

Conditions
Myelodysplastic Syndromes
Interventions
PROCEDURE

Blood test

"Blood is collected in order to perform in vitro research:~1. If a routine blood test is performed for clinical tests, the sponsor will receive the results of the Complete blood count (CBC) and an additional blood sample from the same puncture of 20ml to maximum 40ml will be collected for this study.~2. If no routine blood test is performed for clinical tests, a CBC will be performed for the study and an additional blood sample of 20ml to maximum 40ml will be collected.~Additional Bone marrow (BM) material will be obtained from the same puncture performed for routine clinical tests:"

Trial Locations (1)

9103102

Shaare Zedek Medical Center, Jerusalem

Sponsors
All Listed Sponsors
lead

Minovia Therapeutics Ltd.

INDUSTRY

NCT06144515 - Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter